Congress (specifically the House or Senate) won't vote on a psilocybin rescheduling bill before January 3, 2027, when the current Congress ends. No bill has made it out of committee, and party leaders aren't pushing it as a priority. A small bipartisan group of members supports it, but they don't have the votes or the political machinery to force a floor vote.
No psilocybin rescheduling bill has been reported out of committee. Leadership prioritization is elsewhere. A bipartisan coalition exists but is numerically insufficient and organizationally fragmented. No triggering event — FDA approval, major CBO scoring, or leadership deal — is visible on the horizon before the 119th Congress ends.